Transgene-free CRISPR-Cas9 edited wheat lines targeting ARE1 and DST genes to enhance Nitrogen Use Efficiency (NUE) and Water Use Efficiency (WUE). Knockout of these genes has shown 10–20% grain yield gains and up to 25% reduced water needs in prior crop studies. India's exemption of transgene-free CRISPR knockouts from regulation enables near-term farmer deployment.
Wheat production globally consumes roughly 18% of nitrogen fertilizer and 108 billion cubic meters of water annually, making input efficiency a critical priority for food security and farmer profitability. This project applies SDN1-mediated CRISPR-Cas9 genome editing to knock out two key regulatory genes, ARE1 and DST, in elite Indian wheat cultivars to simultaneously improve Nitrogen Use Efficiency (NUE) and Water Use Efficiency (WUE).
ARE1 is a negative regulator of nitrogen assimilation; its inactivation in rice and wheat has been associated with delayed senescence, 10–20% grain yield increases, and improved NUE. DST is a zinc-finger transcription factor linked to drought and salt tolerance; loss-of-function edits in rice have improved WUE and reduced crop water requirements by approximately 25%. Because India's regulatory framework exempts transgene-free CRISPR-Cas9 knockout mutants from GMO oversight, successfully edited lines can move rapidly toward commercial cultivation.
Target genes and traits:
Editing platform and methodology:
Validation pipeline:
The project builds on a fully standardized Agrobacterium-mediated transformation and regeneration system for Indian wheat genotypes, with prior successful CRISPR-Cas9 edits of GW2 and MS1 genes already advanced to the T2 generation in cultivar DBW187. Cas9-free promising lines have been identified in earlier work. The current effort is at the T0/T1 generation stage for ARE1 and DST edits, with molecular and phenotypic characterization underway. Given India's regulatory exemption for transgene-free CRISPR knockouts, successfully validated lines are positioned for relatively rapid farmer deployment following field trials.